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ABSTRACT 
Objective: The present pilot study was designed to evaluate the efficacy of Seenthil sarkarai, a 
Classical Siddha medicine in Moothirakiricharam (Urinary Tract Infection) patients. 
Method: This study was approved by IEC and registered in Clinical Trial Registry of India and 
was conducted at the National Institute of Siddha, Tambaram, Chennai, India. The investigator 
recruited 20 patients of both male and female with an inclusion and exclusion criteria. All the 
patients were treated with Seenthil Sarkarai at the dose level of 2 grams two times a day with 
warm water for 21 days. Dietary regimen was advised for the patients. Study outcome was 
studied with negative Urine culture and also based on the improvement in the reduction of 
Burning micturition, Frequency of micturition, Dysuria with fever, Foul smelling urine. 
Results: The symptoms such as burning micturition, persistent urge to urinate, foul smelling 
urine, and presence of bacteriuria reduced markedly within 21 days of duration. Out of 20 
patients, 12 patients were completely relieved from the compliance of UTI with negative Urine 
culture. The symptoms of UTI were markedly reduced in remaining 8 patients. There were no 
adverse effect reported during the study and no recurrence of UTI was noticed in 12 patients who 
were completely cured. 
Conclusion: Results suggest that the trial drug Seenthil Sarkarai is effective and safe for the 
management of Moothirakiricharam (UTI) and in alleviating recurrences.  
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INTRODUCTION
 Urinary tract infection (UTI) (Moothira-
kiricharam) is considered to be the most common 
and frequent bacterial infection among all age 
groups. Urinary tract infection may be defined as the 
presence of pathogens (microorganisms) in any part 
of the urinary system. Women are significantly more 
likely to experience UTI than in men. Almost 50-60 % 
women will experience UTI during their lifetime. 
Short urethra and behavioral changes such as 
ignoring or resisting the urge to urinate, usage of 
spermicide or diaphragm, stress, poor hygiene are 
tend to be the risk factors for women. Escherichia coli 
is the most common infecting organism and Proteus, 
Klebsiella, Citrobacter, Enterobacter, and 
Pseudomonas spp are the other gram-negative 
microorganisms causing UTI. Gram-positive 
pathogens, such as Enterococcus fecalis, 
Staphylococcus saprophyticus, and group B 
streptococci can also cause urinary tract infections1.  
 Seenthil Sarkarai is a traditionally extracted 
one which is prepared from Tinospora cordifolia. In 
Siddha literature, this medicine is indicated for 
Cystitis which is the main symptom in Urinary tract 
infection. One of the main reasons for the patients to 
choose Siddha medicine is increased bacterial 
resistance to antibiotics. In Siddha system of 
medicine the disease pathology mainly relies upon 
the variations of Three Dhoshas viz. Vatham, Pitham, 
Kabam2. In Siddha a large number of drugs have been 
used for the management of UTI and to prevent its 
recurrence. The present clinical study hypothesis is 
that Seenthil Sarkarai is effective in the prophylaxis 
of urinary tract infection (Moothirakiricharam).  
Urinary Tract Infection & Siddha Philosophy 
The symptoms of UTI are scanty or persistent 
urge to urinate, burning micturition, dysuria, and 
sometimes hematuria, etc. According to Siddha 
Philosophy these symptoms are due to derangements 
in the Pitham and Kapham dhoshas3. The only taste 
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that subsides both the aggravated Pitham and 
Kapham dhoshas is the Bitter taste. So the selected 
drug Seenthil Sarkarai (made by Tinospora cordifolia- 
Seenthil stem) can soothe both the aggravated 
Pitham and Kapham dhoshas due to its bitter taste.4  
Seenthil Sarkarai – Method of Preparation5  
 
Fig 1: Seenthil Sarkarai 
Clean the Seenthil stem (Tinospora cordifolia) 
and crush it. Soak the crushed drug in water and stir 
well. Next day remove the coarse part of the drug 
from the water. Keep the water in the vessel under 
the sunlight for two to three hours until 
sedimentation occurs. Pour out the clear supernatant 
water and collect the sediment. Add some more 
water to this and remove the remaining coarse 
powder. Allow the starch to settle down and collect it 
and then make it to dry. 
Dosage & Duration: 2 gm twice a day after food with 
warm water for 21 days. (Fig 1) 
It is indicated for splenomegaly, jaundice, cold, cough, 
vomiting, cystitis and urinary tract infection.6 
MATERIALS AND METHODS 
This pilot study was conducted in Ayothidoss 
Pandithar Hospital in the OPD of Gunapadam, 
National Institute of Siddha, Tambaram Sanatorium, 
Chennai-47 in accordance with standard protocol 
after obtaining the approval of the Institutional 
Ethical Committee (IEC) (NIS/IEC/10/2016-17/12-
20.05.2016). The study was registered 
retrospectively in the Clinical Trial Registry of India 
(CTRI Reg No: CTRI/2017/05/008558). Before 
enrollment into the study the informed consent was 
obtained from the patients.  
Plan of Study 
Twenty patients of either sex, of age groups 
between 14 & 60 years of age with complaints like 
difficulty in micturition, burning micturition, 
persistent urge to urinate, foul smelling urine etc., 
were recruited from the outpatient department of the 
Department of Gunapadam, Ayothidoss Pandithar 
Hospital, National Institute of Siddha and were 
enrolled in this study after proper clinical and 
physical examinations as per the screening and 
selection proforma. Complete clinical examinations, 
haematological investigations, routine and 
microscopic examinations of urine, culture and 
sensitivity test of urine were done on each patient. 
The presence of infection was confirmed by urine 
culture using a ‘mid-stream’ urine sample. 
In this study, the patients with UTI who 
suffered from medical renal disease, pregnancy, any 
serious systemic illness, other infectious diseases like 
AIDS, tuberculosis were excluded. 
The patients were instructed and explained 
the merits and modalities of treatment. Antibiotic 
and alkalising drugs, which are commonly used in 
UTI, were withdrawn. Seenthil Sarkarai was given at 
a dose of 2 grams twice a day after food for 21 days. 
The patients were assessed weekly on the basis of 
their symptoms and clinical findings for 21 days. All 
the laboratory investigations were also done before 
and after the treatment to evaluate the clinical 
efficacy of Seenthil Sarkarai. 
Observations 
Age incidence: Twenty cases of UTI were allocated 
in which the youngest patient was 21 years old while 
the oldest was 60 years old. 
Sex incidence: In the present clinical study, the 
majority of patients were female (95%) and only 1 
patient (5%) was male. 
Culture study of urine: Bacteriuria was found in 
100% cases showing three different types of micro-
organisms. E. coli was the most common micro-
organism present in 60 % cases. During the course of 
therapy, bacterial count gradually fell and after 21 
days of treatment, bacteriuria was persistent only in 
8 cases and in 12 cases, urine was found sterile. 
(Table 1)  
Subjective and objective parameters 
 20 patients complained of burning 
micturition, 17 patients had frequency of urination, 8 
patients had severe dysuria with mild fever and 12 
patients complained of foul smelling urine as a 
presenting symptom (Table II). Urine culture was 
done in all the 20 patients before starting the 
treatment. The culture was positive in 100% of 
patients. Out of these 20 patients, 12 patients had E. 
coli, 7 patients had Klebsiella and 1 patient had 
citrobacter sp. 
Study Outcome 
 Study outcome was studied based on the 
urine culture reports, improvement in the reduction 
of clinical symptoms and prevention of recurrence of 
Urinary tract infection for at least 3 months.  
      
 
Elakkiyaa. V et al. Efficacy of Siddha Medicine Seenthil Sarkarai in the management of Moothirakiricharam 
     IJAPR | June 2018 | Vol 6 | Issue 6  15 
Table 1: Trial drug Seenthil Sarkarai was recorded after every seven days 
S.No Age Sex 
Before Treatment After Treatment 
Colony count CFU/ml Colony count CFU/ml 
1 60 F >1,00,000 1,000 
2 29 F 1,00,000 70,000 
3 48 F >1,00,000 >1,00,000 
4 41 F 50,000 10,000 
5 21 F 70,000 60,000 
6 47 F 30,000 1000 
7 42 F >1,00,000 >1,00,000 
8 41 F >1,00,000 60,000 
9 48 F 1,00,000 No Growth 
10 34 F 10,000 No Growth 
11 53 F 1,00,000 No Growth 
12 50 F 1,00,000 No Growth 
13 44 F 70,000 No Growth 
14 55 F 25,000 No Growth 
15 58 F >1,00,000 No Growth 
16 49 F 80,000 No Growth 
17 55 F 1,00,000 No Growth 
18 47 M 15,000 No Growth 
19 27 F >1,00,000 No Growth 
20 49 F >1,00,000 No Growth 
 The response to the trial drug Seenthil Sarkarai was recorded after every seven days. There was marked 
relief in burning micturition (90%) and frequency of micturition (82.35%). 11 out of 12 patients relieved from 
foul smelling urine (91.67%), whereas all the patients had complete relief of dysuria with mild fever after 21 
days. (Table 2)  
Table 2: Clinical Response after 21 days 
Symptoms No. of patients 
 Relief 
No. of patients % 
Burning micturition 20 18 90 
Frequency of micturition 17 14 82.35 
Dysuria with mild fever 8 8 100 
Foul smelling urine 12 11 91.67 
 
The causative pathogen citrobacter sp. was completely eliminated, whereas 8 of 12 cases of Escherichia 
coli and 3 of 7 cases of Klebsiella showed negative culture. It also suggest that the drug Seenthil Sarkarai is 
specifically sensitive to Escherichia coli, Klebsiella, citrobacter sp. (Table 3) 
Table 3: Effect of Seenthil Sarkarai on the pathogens 
Organism 
Culture positive 
before treatment 
Culture negative after treatment 
No. % 
E. coli 12 8 66.67 
Klebsiella 7 3 42.86 
Citrobacter sp 1 1 100 
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RESULTS 
Clinical symptoms such as burning micturition, frequency of micturition, foul smelling urine, dysuria 
with mild fever were relieved during the treatment. On completion of treatment, no drug dependency and side 
effects were observed. There was no recurrence of UTI in 4 patients who were completely cured, during the 
follow up period of up to 3 months and in all other patients the symptoms of UTI and bacterial load was 
markedly reduced.  
Statistical Data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistical data 
Before treatment  After treatment 
Heavy Infection Low infection 
Heavy infection 2 10 
Low Infection 0 8 
The statistical data was evaluated using McNemar Test.  
Statistics a   
 Before & after treatment 
N 20 
Exact Sig. (2-tailed) .002b 
 Since the p value is less than 0.05, which is statistically significant (p<0.02), the finding of the study 
showed that the Seenthil Sarkarai was effective among the UTI Patients. 
DISCUSSION 
The cost effective and highly efficient drug 
which has been mentioned in Classical Siddha 
literature for the management of Moothira 
kiricharam (UTI) was used for the trial. A total 
number of 30 cases were screened and 20 cases was 
recruited and given treatment in the Gunapadam 
OPD. After completion of the study, the patients were 
advised to visit the OPD of Gunapadam for 3 month 
for follow up. The results obtained provide promising 
good result. Among 20 cases, 60% shows excellent 
improvement and 40% shows moderate 
improvement. These results were based completely 
on the urine culture test and clinical improvements. 
CONCLUSION  
The trial drug Seenthil Sarkarai has been 
quite effective in controlling and relieving clinical 
symptoms of Moothira kiricharam (UTI) significantly, 
which is observed clinically and statistically. The 
present study also demonstrated antimicrobial 
efficacy of the drug against the common pathogens 
Escherichia coli, Klebsiella, citrobacter sp. At the end 
of the study, the associated symptoms like burning 
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micturition, frequency of micturition relieved 
significantly and urine pus cells and epithelial cells 
responded well with Seenthil Sarkarai. It does not 
show any toxic effect during the course of therapy. 
Hence, it can be concluded that Seenthil Sarkarai can 
be used safely for effective control of Moothira 
kiricharam (UTI). 
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